Skin barrier therapy and neonatal mortality in preterm infants

Pediatrics

Volumn 123, Issue 2, 2009, Pages

  Bharathi, Mangala ^a   Sundaram, Venkataseshan ^a   Kumar, Praveen ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL TRIAL; HOSPITAL INFECTION; HUMAN; LETTER; NEWBORN MORTALITY; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SKIN BARRIER THERAPY; SKIN CARE; CROSS INFECTION; MORTALITY; NEWBORN; NOTE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CROSS INFECTION; EMOLLIENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES;

EMOLLIENT AGENT;

EID: 61549083077     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2307     Document Type: Letter

References (2)

1. Darmstadt GL, Saha SK, Ahmed AS, et al. A randomized controlled clinical trial effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh. Pediatrics. 2008;121(3):522-529
2. Darmstadt GL, Saha SK, Ahmed AS, et al. Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh a randomized controlled trial. Lancet. 2005;365(9464):1039- 1045